- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 29.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 25.02M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 13.4M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $940K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$17.98M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$12.35M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $16.56M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $39.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $3.87M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $51.54M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $38.16M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $32.8M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $39.66M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $26.62M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $33.8M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $40.86M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $67.19M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $65.17M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $80.12M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $92.4M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $105.35M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.87 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.87 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.91M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $9.08M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.7M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $2.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$7M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$25.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.95M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$11.52M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.38M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $697K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $11.44M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $8.62M |
| Revenue | Q1 2026 · Mar 31, 2026 | $13.82M |
| Revenue | Q1 2026 · Mar 31, 2025 | $9.32M |